N–дезацетиллаппаконитин (N-ДАЛ) нинг фармакодинамик ва антифибриллятор таъсирини экспериментал ўрганиш
Автор: Толмас Толибович Ҳамроев, Зафар Исомиддинович Саноев, Иброҳим Тўйчиевич Абдиназаров, Матлюба Абдухаликовна Азизова, Сухроб Давлатёр Рахимбоев, Сохиб Замон Рашидов
Журнал: Life Sciences and Agriculture.
Рубрика: Медицинские науки
Статья в выпуске: 3-4 (7-8), 2021 года.
Бесплатный доступ
Ушбу мақолада N–дезацетиллаппаконитиннинг 0,01; 0,05; 0,1; 0,5; 1,0 ва 2,0 мг/кг дозаларда оқ каламушларда оғиз орқали юборилганда аконитин ёрдамида чақирилган аритмия модели орқали модданинг ва солиштирма препаратлар аллапинин ҳамда пропафенонларнинг фармокодинамик кўрсаткичлари ўрганиб чиқилди. N–дезацетиллаппаконитиннинг турли дозаларда антифибриллятор таъсири ўрганилди ва керакли хулосалар олинди.
N–дезацетиллаппаконитин, аритмия, аконитин, антифибрилятор, аллапинин, пропафенон
Короткий адрес: https://sciup.org/14124715
IDR: 14124715
Список литературы N–дезацетиллаппаконитин (N-ДАЛ) нинг фармакодинамик ва антифибриллятор таъсирини экспериментал ўрганиш
- Gorenek B., Blomstrom Lundqvist C., Brugada Terradellas J., et al. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. Europace. 2014; 16:1655-73.
- Rahimi K., Watzlawek S., Thiele H., et al. Incidence, time course, and predictors of early malignant ventricular arrhythmias after non-ST-segment elevation myocardial infarction in patients with early invasive treatment. Eur Heart J. 2006; 27:1706-11.
- Gogolashvili N.G., Litvinenko M.V., Pochikaeva T.N., et al. Ventricular arrhythmia prevalence and treatment with omega-3 polyunsaturated fatty acids in patients who suffered myocardial infarction within the last year. Kardiovaskulyarnaya Terapiya i Profilaktika. 2011;10(5):57-62.
- Gogolashvili N.G., Litvinenko M.V., Pochikaeva T.N. et al. Possibilities of apreparation omega-3 polyunsaturated fatty acids in the treatment of patients with ventricular arrhythmias and myocardial infarction. Kardiologiia. 2011;51(8):28-31.
- Parmon E.V., Treshkur T.V., Shlyakhto E.V. Idiopathic ventricular arrhythmias (problem analysis). Vestnik Aritmologii. 2003; 31:60-71
- Hwang J.K., Park S.J., On Y.K., et al. Clinical characteristics and features of frequent idiopathic ventricular premature complexes in the Korean population. Korean Circ J. 2015;45(5):391-7.
- Cheriyath P., He F., Peters I., et al. Relation of atrial and/or ventricular premature complexes on a twominute rhythm strip to the risk of sudden cardiac death (the atherosclerosis risk in communities [ARIC] study). Am J Cardiol. 2011;107(2):151-5.
- Ephrem G., Levine M., Friedmann P., Schweitzer P. The prognostic significance of frequency and morphology of premature ventricular complexes during ambulatory holter monitoring. Ann Noninvasive Electrocardiol. 2013;18(2):118-25.
- Agarwal S.K., Simpson R.J. Jr., Rautaharju P., et al. Relation of ventricular premature complexes to heart failure (from the Atherosclerosis Risk In Communities [ARIC] Study). Am J Cardiol. 2012;109(1): 105-9.
- Piccini J.P., White J.A., Mehta R.H., et al. Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes. Circulation. 2012;126(1): 41-9.
- Mamchur S.E., Ardashev A.V. Sudden cardiac death and Wolff-Parkinson-White syndrome. Vestnik Aritmologii. 2014; 76:30-6.
- Dukes J.W., Dewland T.A., Vittinghoff E., et al. Ventricular ectopy as a predictor of heart failure and death. J Am Coll Cardiol. 2015;66(2):101-9
- Sanoev Z.I., Khamroev T.T., Djaxangirov F.N., Sadikov A.Z., Sagdullaev S.S. Antiarrhythmic activity of n-deacety lappaconitine when administered orally. Annals of the Romanian Society for Cell Biology, 2021, 25(2), стр. 2339–2346
- Zakhidova L.T., Saidkhodjaeva D.M., Khamroev T.T., Sanoev Z.I., Tukhtasheva V.F., Rakhmanova H.A. (2021). Toxicological Characteristics Of N-Deacetyllappaconitine Under Chronic Administration In White Rats. The American Journal of Applied Sciences, 3(03), 34-41. IF 5.634, https://doi.org/10.37547/tajas/Volume03Issue03-06
- Khamroev T.T., Sanoev Z.I., Abdinazarov I.T., Rakhimboev S.D., Rashidov S.Z. (2021). Study Of The General Pharmacological Properties Of A New Antiarrhythmic N-Deacetyllappaconitine With Oral Administration. The American Journal of Medical Sciences and Pharmaceutical Research, 3(03), 60-64. IF 5.64. https://doi.org/10.37547/TAJMSPR/Volume03Issue03-08
- Khamroev, T. T., Sanoev, Z. I., Rakhimboev, S. D., Abdinazarov, I. T., & Rashidov, S. Z. (2021). Effect of anti-arrhythmic substance N – dezacetyllapoconitin on the central nervous system. ISJ Theoretical & Applied Science, 07 (99), 153-157. Soi: http://s-o-i.org/1.1/TAS-07-99-31 Doi: https://dx.doi.org/10.15863/TAS
- European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes, ETS №123, Strasbourg (1986).
- Стефанов А.В. Доклинические исследования лекарственных средств. - Киев: Авиценна, 2002. - 568 с.
Статья научная
